-
1
-
-
0036355398
-
Drug resistance in epilepsy: The role of the blood-brain barrier
-
Abbott NJ, Khan EU, Rollinson CM, Reichel A, Janigro D, Dombrowski SM, Dobbie MS, and Begley DJ (2002) Drug resistance in epilepsy: the role of the blood-brain barrier. Novartis Found Symp 243:38-47.
-
(2002)
Novartis Found Symp
, vol.243
, pp. 38-47
-
-
Abbott, N.J.1
Khan, E.U.2
Rollinson, C.M.3
Reichel, A.4
Janigro, D.5
Dombrowski, S.M.6
Dobbie, M.S.7
Begley, D.J.8
-
3
-
-
0031883784
-
Carbamazpine toxicity with lamotrigine: Pharmacokinetic or pharmacodynamic interaction?
-
Besag FM, Berry DJ, Pool F, Newbery JE, and Subel B (1998) Carbamazpine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction? Epilepsia 29:183-187.
-
(1998)
Epilepsia
, vol.29
, pp. 183-187
-
-
Besag, F.M.1
Berry, D.J.2
Pool, F.3
Newbery, J.E.4
Subel, B.5
-
4
-
-
0034611017
-
In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity
-
Chen Y and Simon SM (2000) In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity. J Cell Biol 148:863-870.
-
(2000)
J Cell Biol
, vol.148
, pp. 863-870
-
-
Chen, Y.1
Simon, S.M.2
-
5
-
-
0000712439
-
Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
-
Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, and Bertino JR (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695-698.
-
(1989)
Proc Natl Acad Sci USA
, vol.86
, pp. 695-698
-
-
Cordon-Cardo, C.1
O'Brien, J.P.2
Casals, D.3
Rittman-Grauer, L.4
Biedler, J.L.5
Melamed, M.R.6
Bertino, J.R.7
-
6
-
-
0037130989
-
Synergistic interaction between valproate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice
-
Cuadrado A, de las Cuevas I, Valdizán EM, and Armino JA (2002) Synergistic interaction between valproate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice. Eur J Pharmacol 453:43-52.
-
(2002)
Eur J Pharmacol
, vol.453
, pp. 43-52
-
-
Cuadrado, A.1
De las Cuevas, I.2
Valdizán, E.M.3
Armino, J.A.4
-
7
-
-
0033761218
-
Selection of antiepileptic drug polytherapy based on mechanisms of action: The evidence reviewed
-
Deckers CLP, Czuczwar SJ, Hekster YA, Keyser A, Kubova H, Meinardi H, Patsalos PN, Renier WO, and van Rijn CM (2000) Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 41:1364-1374.
-
(2000)
Epilepsia
, vol.41
, pp. 1364-1374
-
-
Deckers, C.L.P.1
Czuczwar, S.J.2
Hekster, Y.A.3
Keyser, A.4
Kubova, H.5
Meinardi, H.6
Patsalos, P.N.7
Renier, W.O.8
Van Rijn, C.M.9
-
8
-
-
0035669389
-
Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy
-
Dombrowski SM, Desai SY, Marroni M, Cucullo L, Goodrich K, Bingaman W, Mayberg MR, Bengez L, and Janigro D (2001) Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 42:1501-1506.
-
(2001)
Epilepsia
, vol.42
, pp. 1501-1506
-
-
Dombrowski, S.M.1
Desai, S.Y.2
Marroni, M.3
Cucullo, L.4
Goodrich, K.5
Bingaman, W.6
Mayberg, M.R.7
Bengez, L.8
Janigro, D.9
-
9
-
-
0037373631
-
P-glycoprotein-mediated intestinal and biliary digoxin transport in humans
-
Drescher S, Glaeser H, Murdter T, Hitzl M, Eichelbaum M, and Fromm MF (2003) P-glycoprotein-mediated intestinal and biliary digoxin transport in humans. Clin Pharmacol Ther 73:223-231.
-
(2003)
Clin Pharmacol Ther
, vol.73
, pp. 223-231
-
-
Drescher, S.1
Glaeser, H.2
Murdter, T.3
Hitzl, M.4
Eichelbaum, M.5
Fromm, M.F.6
-
10
-
-
0018168207
-
Distribution of valproate across the interface between blood and cerebrospinal fluid
-
Frey HH and Löscher W (1978) Distribution of valproate across the interface between blood and cerebrospinal fluid. Neuropharmacology 17:637-642.
-
(1978)
Neuropharmacology
, vol.17
, pp. 637-642
-
-
Frey, H.H.1
Löscher, W.2
-
12
-
-
0027432409
-
Fluorescent cellular indicators are extruded by the multidrug resistance protein
-
Homolya L, Hollo Z, Germann UA, Pastan I, Gottesman MM, and Sarkadi B (1993) Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem 268:21493-21496.
-
(1993)
J Biol Chem
, vol.268
, pp. 21493-21496
-
-
Homolya, L.1
Hollo, Z.2
Germann, U.A.3
Pastan, I.4
Gottesman, M.M.5
Sarkadi, B.6
-
13
-
-
0032562111
-
Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells
-
Huai-Yun H, Secrest DT, Mark KS, Carney D, Brandquist C, Elmquist WF, and Miller DW (1998) Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochem Biophys Res Commun 243:816-820.
-
(1998)
Biochem Biophys Res Commun
, vol.243
, pp. 816-820
-
-
Huai-Yun, H.1
Secrest, D.T.2
Mark, K.S.3
Carney, D.4
Brandquist, C.5
Elmquist, W.F.6
Miller, D.W.7
-
15
-
-
0031691234
-
The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs
-
Kusuhara H, Suzuki H, and Sugiyama Y (1998) The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs. J Pharm Sci 87:1025-1040.
-
(1998)
J Pharm Sci
, vol.87
, pp. 1025-1040
-
-
Kusuhara, H.1
Suzuki, H.2
Sugiyama, Y.3
-
16
-
-
0026095124
-
Fluorescent verapamil derivative for monitoring activity of the multi-drug transporter
-
Lelong IH, Guzikowski AP, Haugland RP, Pastan I, Gottesman MM, and Willingham MC (1991) Fluorescent verapamil derivative for monitoring activity of the multi-drug transporter. Mol Pharmacol 40:490-494.
-
(1991)
Mol Pharmacol
, vol.40
, pp. 490-494
-
-
Lelong, I.H.1
Guzikowski, A.P.2
Haugland, R.P.3
Pastan, I.4
Gottesman, M.M.5
Willingham, M.C.6
-
17
-
-
0036128985
-
Role of multidrug transporters in pharmacoresistance to antiepileptic drugs
-
Löscher W and Potschka H (2002) Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 301:7-14.
-
(2002)
J Pharmacol Exp Ther
, vol.301
, pp. 7-14
-
-
Löscher, W.1
Potschka, H.2
-
19
-
-
0032920526
-
Lamotrigine concentrations in human serum, brain tissue and tumor tissue
-
Meyer FP, Banditt P, Schubert A, and Schoche J (1999) Lamotrigine concentrations in human serum, brain tissue and tumor tissue. Epilepsia 40:68-73.
-
(1999)
Epilepsia
, vol.40
, pp. 68-73
-
-
Meyer, F.P.1
Banditt, P.2
Schubert, A.3
Schoche, J.4
-
20
-
-
0035036730
-
Carbamazepine is not a substrate for P-glycoprotein
-
Owen A, Pirmohamed M, Tettey JN, Morgan P, Chadwick D, and Park BK (2001) Carbamazepine is not a substrate for P-glycoprotein. Br J Clin Pharmacol 51:345-349.
-
(2001)
Br J Clin Pharmacol
, vol.51
, pp. 345-349
-
-
Owen, A.1
Pirmohamed, M.2
Tettey, J.N.3
Morgan, P.4
Chadwick, D.5
Park, B.K.6
-
22
-
-
0035900333
-
P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain
-
Potschka H, Fedrowitz M, and Löscher W (2001) P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain. Neuroreport 12:3557-3560.
-
(2001)
Neuroreport
, vol.12
, pp. 3557-3560
-
-
Potschka, H.1
Fedrowitz, M.2
Löscher, W.3
-
23
-
-
0037178642
-
P-glycoprotein-mediated efflux of phenobarbital, lamotrigine and felbamate at the blood-brain barrier: Evidence from microdialysis experiments in rats
-
Potschka H, Fedrowitz M, and Löscher W (2002) P-glycoprotein-mediated efflux of phenobarbital, lamotrigine and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats. Neurosci Lett 327:173-176.
-
(2002)
Neurosci Lett
, vol.327
, pp. 173-176
-
-
Potschka, H.1
Fedrowitz, M.2
Löscher, W.3
-
24
-
-
0035167174
-
In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats
-
Potschka H and Löscher W (2001a) In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats. Epilepsia 42:1231-1240.
-
(2001)
Epilepsia
, vol.42
, pp. 1231-1240
-
-
Potschka, H.1
Löscher, W.2
-
25
-
-
0035828178
-
Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain
-
Potschka H and Löscher W (2001b) Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain. Neuroreport 12:2387-2389.
-
(2001)
Neuroreport
, vol.12
, pp. 2387-2389
-
-
Potschka, H.1
Löscher, W.2
-
27
-
-
0032918385
-
Clinical aspects and biological bases of drug-resistant epilepsies
-
Regesta G and Tanganelli P (1999) Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res 34:109-122.
-
(1999)
Epilepsy Res
, vol.34
, pp. 109-122
-
-
Regesta, G.1
Tanganelli, P.2
-
28
-
-
0028229150
-
Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
-
Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te Riele HP, et al. (1994) Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.
-
(1994)
Cell
, vol.77
, pp. 491-502
-
-
Schinkel, A.H.1
Smit, J.J.2
Van Tellingen, O.3
Beijnen, J.H.4
Wagenaar, E.5
Van Deemter, L.6
Mol, C.A.7
Van der Valk, M.A.8
Robanus-Maandag, E.C.9
Te Riele, H.P.10
-
29
-
-
0029892497
-
P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
-
Schinkel AH, Wagenaar E, Mol CA, and van Deemter L (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Investig 97:2517-2524.
-
(1996)
J Clin Investig
, vol.97
, pp. 2517-2524
-
-
Schinkel, A.H.1
Wagenaar, E.2
Mol, C.A.3
Van Deemter, L.4
-
30
-
-
0037431040
-
Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1
-
Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, Wood NW, and Sisodiya SM (2003) Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 348:1442-1448.
-
(2003)
N Engl J Med
, vol.348
, pp. 1442-1448
-
-
Siddiqui, A.1
Kerb, R.2
Weale, M.E.3
Brinkmann, U.4
Smith, A.5
Goldstein, D.B.6
Wood, N.W.7
Sisodiya, S.M.8
-
31
-
-
0018908576
-
Antiepileptic drug distribution in cerebral cortex, ammon's horn and amygdala in man
-
Sironi VA, Cabrini G, Porro MG, Ravagnati L, and Marossero F (1980) Antiepileptic drug distribution in cerebral cortex, ammon's horn and amygdala in man. J Neurosurg 52:686-692.
-
(1980)
J Neurosurg
, vol.52
, pp. 686-692
-
-
Sironi, V.A.1
Cabrini, G.2
Porro, M.G.3
Ravagnati, L.4
Marossero, F.5
-
32
-
-
0036156280
-
Drug resistance in epilepsy: Expression of drug resistance proteins in common causes of refractory epilepsy
-
Sisodiya SM, Lin WR, Harding BN, Squier MV, and Thom M (2002) Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125:22-31.
-
(2002)
Brain
, vol.125
, pp. 22-31
-
-
Sisodiya, S.M.1
Lin, W.R.2
Harding, B.N.3
Squier, M.V.4
Thom, M.5
-
33
-
-
0032977818
-
Clinically significant pharmacokinetic drug interactions between antiepileptic drugs
-
Tanaka E (1999) Clinically significant pharmacokinetic drug interactions between antiepileptic drugs. J Clin Pharm Ther 24:87-92.
-
(1999)
J Clin Pharm Ther
, vol.24
, pp. 87-92
-
-
Tanaka, E.1
-
34
-
-
0028895740
-
MDR1 gene expression in brain of patients with medically intractable epilepsy
-
Tishler DM, Weinberg KI, Hinton DR, Barbaro N, Annett GM, and Raffel C (1995) MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 36:1-6.
-
(1995)
Epilepsia
, vol.36
, pp. 1-6
-
-
Tishler, D.M.1
Weinberg, K.I.2
Hinton, D.R.3
Barbaro, N.4
Annett, G.M.5
Raffel, C.6
-
36
-
-
0032101275
-
The pharmacological role of P-glycoprotein in the intestinal epithelium
-
van Asperen J, van Tellingen O, and Beijnen JH (1998) The pharmacological role of P-glycoprotein in the intestinal epithelium. Pharmacol Res 37:429-435.
-
(1998)
Pharmacol Res
, vol.37
, pp. 429-435
-
-
Van Asperen, J.1
Van Tellingen, O.2
Beijnen, J.H.3
-
37
-
-
0035976774
-
Active transport of fluorescent P-glycoprotein substrates: Evaluation as markers and interaction with inhibitors
-
Wang EJ, Casciano CN, Clement RP, and Johnson WW (2001) Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors. Biochem Biophys Res Commun 289:580-585.
-
(2001)
Biochem Biophys Res Commun
, vol.289
, pp. 580-585
-
-
Wang, E.J.1
Casciano, C.N.2
Clement, R.P.3
Johnson, W.W.4
-
38
-
-
0037379938
-
Inhibition of P-glycoprotein by newer antidepressants
-
Weiss J, Dormann S-MG, Martin-Facklam M, Kerpen CJ, Ketabi-Kiyanvash N, and Haefeli WE (2003) Inhibition of P-glycoprotein by newer antidepressants. J Pharmacol Exp Ther 305:197-204.
-
(2003)
J Pharmacol Exp Ther
, vol.305
, pp. 197-204
-
-
Weiss, J.1
Dormann, S.-M.G.2
Martin-Facklam, M.3
Kerpen, C.J.4
Ketabi-Kiyanvash, N.5
Haefeli, W.E.6
-
39
-
-
0036784516
-
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein
-
Yasuda K, Lan LB, Sanglard D, Furuya K, Schuetz JD, and Schuetz EG (2002) Interaction of cytochrome P450 3A inhibitors with P-glycoprotein. J Pharmacol Exp. Ther 303:323-332.
-
(2002)
J Pharmacol Exp Ther
, vol.303
, pp. 323-332
-
-
Yasuda, K.1
Lan, L.B.2
Sanglard, D.3
Furuya, K.4
Schuetz, J.D.5
Schuetz, E.G.6
-
40
-
-
0033328139
-
The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions
-
Yu DK (1999) The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions. J Clin Pharmacol 39:1203-1211.
-
(1999)
J Clin Pharmacol
, vol.39
, pp. 1203-1211
-
-
Yu, D.K.1
|